Significantly higher disease activity markers, including serum levels of C-reactive protein (CRP) and DAS28-ESR scores, were also found in patients with moderate-to-severe NAFLD than in those with none-to-mild NAFLD. Here, CRP is linked to metabolic dysfunction-associated steatotic liver disease.